.
cambridge's bluebird bio licenses delivery tech to novartis, gsk.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
.

.
chemotherapy involved two hours at the hospital every other week. he'd leave wearing a fanny pack that would continue to deliver treatment for 48 straight hours, one slow drip at a time.